ANP has travelled a long and bumpy road over the past 18 years. Three drugs past ph 2 clinical trial but no ongoing partnerships or deals. Contracts struck with Teva and Cortendo both fell through in the finish so most investors have lost faith in Marks ability to negotiate a deal or bring the products to market. In saying that, as a long term holder, I honestly believe this time we are on a winner and I expect this little minnow to be gobbled up soon by big Pharma. I'm calling a takeover price of 50 cents this year before the trial is complete and I will happily accept. I'm a top 20 holder and still accumulating.
Chart, page-1098
-
- There are more pages in this discussion • 4,808 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |